BridgeBio Pharma
BBIO
BBIO
200 hedge funds and large institutions have $8.46B invested in BridgeBio Pharma in 2021 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 80 increasing their positions, 60 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more capital invested
Capital invested by funds: $8.45B → $8.46B (+$10.4M)
0% more funds holding in top 10
Funds holding in top 10: 15 → 15 (0)
33% less call options, than puts
Call options by funds: $19.2M | Put options by funds: $28.7M
Holders
200
Holding in Top 10
15
Calls
$19.2M
Puts
$28.7M
Top Buyers
| 1 | +$121M | |
| 2 | +$27.8M | |
| 3 | +$26.7M | |
| 4 |
BlackRock
New York
|
+$26.1M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
+$23.2M |
Top Sellers
| 1 | -$107M | |
| 2 | -$41.7M | |
| 3 | -$28.5M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$24.9M |
| 5 |
BAMCO Inc
New York
|
-$19.6M |